CTOs on the Move

Temps Bed

www.tempsbed.com

 
Temps Bed is a Elkhart, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

ARS Dental Inc

ARS Dental Inc is a Rialto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nature’s Medicines

Whether you`re new to the wonders of cannabis, or a longtime connoisseur, Nature`s Medicines is here to guide you. Our number one goal is to inspire you on your personal self-care journey - and educate you along the way.

LinkCore Pharma

LinkCore Pharma is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Trulieve

Trulieve is Florida`s first Medical Marijuana dispensing organization. At Trulieve, we strive to bring you the relief you need in a product you can trust. Our plants are hand-grown in an environment specially designed to reduce unwanted chemicals and pests, keeping the process as natural as possible at every turn.

www.biosig.com

BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.